MD PEDIATRIX MEDICAL GROUP INC revenue, earnings and financials

For the quarter ended June 30, 2026, PEDIATRIX MEDICAL GROUP INC reported revenue of $488M (up 4.0% from a year earlier), net income of $39.8M and diluted EPS of $0.49; over the last four quarters revenue was $1.95B and net income $175M; for the fiscal year ended December 2025 revenue was $1.91B, down 4.9% on the year before.

MD annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.91B, gross profit n/a, operating income $209M, net income $165M (margin 8.6%), EPS $1.94
• Fiscal year ended Dec 2024: revenue $2.01B, gross profit n/a, operating income −$68.7M, net income −$99.1M (margin -4.9%), EPS −$1.19
• Fiscal year ended Dec 2023: revenue $1.99B, gross profit n/a, operating income $7.32M, net income −$60.4M (margin -3.0%), EPS −$0.73
• Fiscal year ended Dec 2022: revenue $1.97B, gross profit n/a, operating income $173M, net income $66.3M (margin 3.4%), EPS $0.79
• Fiscal year ended Dec 2021: revenue $1.91B, gross profit n/a, operating income $203M, net income $131M (margin 6.9%), EPS $1.53

MD quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $488M (up 4.0% year over year), net income $39.8M, EPS $0.49
• Quarter ended Mar 31, 2026: revenue $476M (up 3.9% year over year), net income $29.6M, EPS $0.36
• Quarter ended Dec 31, 2025 (from the annual report): revenue $494M (down 1.7% year over year), net income $33.7M, EPS $0.40
• Quarter ended Sep 30, 2025: revenue $493M (down 3.6% year over year), net income $71.7M, EPS $0.84
• Quarter ended Jun 30, 2025: revenue $469M (down 7.0% year over year), net income $39.3M, EPS $0.46
• Quarter ended Mar 31, 2025: revenue $458M (down 7.4% year over year), net income $20.7M, EPS $0.24
• Quarter ended Dec 31, 2024 (from the annual report): revenue $502M (up 1.2% year over year), net income $30.5M, EPS $0.37
• Quarter ended Sep 30, 2024: revenue $511M (up 0.9% year over year), net income $19.4M, EPS $0.23
• Quarter ended Jun 30, 2024: revenue $504M (up 0.7% year over year), net income −$153M, EPS −$1.84
• Quarter ended Mar 31, 2024: revenue $495M (up 0.8% year over year), net income $4.04M, EPS $0.05
• Quarter ended Dec 31, 2023 (from the annual report): revenue $496M (down 3.4% year over year), net income −$124M, EPS −$1.50
• Quarter ended Sep 30, 2023: revenue $507M (up 3.4% year over year), net income $21.4M, EPS $0.26
• Quarter ended Jun 30, 2023: revenue $501M (up 3.0% year over year), net income $28.3M, EPS $0.34
• Quarter ended Mar 31, 2023: revenue $491M (up 1.8% year over year), net income $14.2M, EPS $0.17
• Quarter ended Dec 31, 2022 (from the annual report): revenue $514M (up 3.1% year over year), net income $29.7M, EPS $0.35
• Quarter ended Sep 30, 2022: revenue $490M (down 0.6% year over year), net income $30.7M, EPS $0.37
• Quarter ended Jun 30, 2022: revenue $486M (up 2.8% year over year), net income $27.1M, EPS $0.32
• Quarter ended Mar 31, 2022: revenue $482M (up 7.9% year over year), net income −$21.2M, EPS −$0.25
• Quarter ended Dec 31, 2021 (from the annual report): revenue $499M, net income $47.5M, EPS $0.55
• Quarter ended Sep 30, 2021: revenue $493M, net income $30.8M, EPS $0.36

MD cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $271M, share buybacks $86.7M
• Fiscal year ended Dec 2024: operating cash flow $207M, share buybacks $1.70M
• Fiscal year ended Dec 2023: operating cash flow $137M, share buybacks $919K
• Fiscal year ended Dec 2022: operating cash flow $167M, share buybacks $88.5M
• Fiscal year ended Dec 2021: operating cash flow $76.7M, share buybacks $4.72M

MD balance sheet

• Jun 30, 2026: cash $289M, total assets $2.13B, total liabilities $1.25B, shareholders' equity $881M
• Mar 31, 2026: cash $206M, total assets $2.07B, total liabilities $1.19B, shareholders' equity $879M
• Dec 31, 2025: cash $375M, total assets $2.25B, total liabilities $1.38B, shareholders' equity $866M
• Sep 30, 2025: cash $340M, total assets $2.20B, total liabilities $1.31B, shareholders' equity $891M
• Jun 30, 2025: cash $225M, total assets $2.10B, total liabilities $1.27B, shareholders' equity $834M
• Mar 31, 2025: cash $99.0M, total assets $1.99B, total liabilities $1.20B, shareholders' equity $789M
• Dec 31, 2024: cash $230M, total assets $2.15B, total liabilities $1.39B, shareholders' equity $765M
• Sep 30, 2024: cash $104M, total assets $2.08B, total liabilities $1.34B, shareholders' equity $732M

What is MD's revenue?

PEDIATRIX MEDICAL GROUP INC reported $1.95B of revenue over its last four quarters, through June 30, 2026.

Is MD profitable?

Yes. PEDIATRIX MEDICAL GROUP INC earned $175M over the last four quarters.

What is MD's EPS?

Diluted earnings per share over the last four quarters were $2.09; $0.49 in the latest quarter.

MD ownership and insider trades · All stocks